Table 4.

Clinical characteristics in HALT-C cohort

	Diabetes (+) (N =80; %)	Diabetes (−) (N =330; %)	P-value
Age	52±7	50±7	0.01
Gender (male)	53 (66)	245 (74)	0.16
Race (Caucasian)	50 (63)	244 (74)	0.05
BMI	32±5	30±5	<0.01
Ascites	0 (0)	0 (0)	1.00
Hepatic encephalopathy	0 (0)	0 (0)	1.00
International normalized ratio	1.1±0.1	1.1±0.1	0.05
HOMA2-IR2	8.3±4.9	5.5±3.7	<0.01
Albumin	3.7±0.4	3.8±0.4	0.01
Creatinine	1.1±1.0	1.0±0.7	0.05
Bilirubin	1.9±3.2	2.9±4.6	<0.01
CTP score	5.4±0.5	5.3±0.5	0.05
Model for End-stage Liver Disease score	7.3±1.4	7.5±1.5	0.12